SCHRODER INVESTMENT MANAGEMENT GROUP - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 319 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 1.3%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$31,551,000
-9.8%
182,800
-39.9%
0.06%
-10.1%
Q4 2014$34,965,000
-99.9%
304,200
+0.3%
0.07%
+9.5%
Q3 2014$47,381,343,000
+16.2%
303,260
-8.3%
0.06%
+23.5%
Q2 2014$40,786,911,000
+4.7%
330,660
-12.1%
0.05%
+15.9%
Q1 2014$38,967,721,000
-38.7%
376,100
-46.8%
0.04%
-44.3%
Q4 2013$63,524,622,000
+24.9%
706,300
-7.1%
0.08%
-35.8%
Q3 2013$50,842,176,000
-3.7%
760,200
-4.8%
0.12%
-12.1%
Q2 2013$52,800,930,000798,2000.14%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 467,943$30,954,00011.01%
TANG CAPITAL MANAGEMENT LLC 300,000$19,845,0007.82%
OAK RIDGE INVESTMENTS LLC 1,382,895$91,478,0002.87%
SECTOR GAMMA AS 147,001$9,724,0002.84%
Credo Capital Management, LLC 38,869$2,571,0001.98%
Cardinal Capital Management 48,226$3,190,0001.89%
ZEVENBERGEN CAPITAL INVESTMENTS LLC 626,800$41,463,0001.68%
HERNDON CAPITAL MANAGEMENT LLC 1,284,472$84,967,823,0001.27%
CATAPULT CAPITAL MANAGEMENT LLC 45,000$2,977,0001.24%
Pier Capital, LLC 108,556$7,181,0001.10%
View complete list of SALIX PHARMACEUTICALS INC shareholders